SEC Form 6-K filed by SHL Telemedicine Ltd

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F ☒      Form 40-F ☐

 

 

On March 11, 2025, SHL Telemedicine Ltd. (the “Company”) issued a press release entitled “SHL Telemedicine Ltd. to Delist from Nasdaq and Terminate its U.S. ADR Program and SEC Reporting Obligations” in connection with its plans to voluntarily delist from the Nasdaq Capital Market, terminate its American Depositary Receipt program and deregister from, and terminate its reporting obligations under, the Securities Exchange Act of 1934, as amended. A copy of the press release is attached to this Form 6-K as Exhibit 99.1 and is incorporated by reference herein.  The press release contains forward-looking statements and includes cautionary statements identifying important factors that could cause actual results to differ materially from those in the forward-looking statements.

 

Exhibit		Description
99.1		Press Release, dated March 11, 2025, issued by SHL Telemedicine Ltd. announcing its plans to voluntarily delist from the Nasdaq Capital Market, terminate its American Depositary Receipt program and deregister from, and terminate its reporting obligations under, the Securities Exchange Act of 1934, as amended.

 

SIGNATURE

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. 

---